NS-229

· NS Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NS-229, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis [Phase 2]

See pricing